Baltimore, MD, United States of America

Thomas Elliot Rabe

This inventor holds 59 USPTO granted patents and 23 published patent applications, plus 27 CIPO patents and 28 EPO patents, primarily in Cosmetic Ink Technology (CPC class A61K). Top assignees: The Procter Gamble Company, Noxell Corporation, The Proctor 'Gamble Company. Active years: 2000-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Elliot Rabe. Retrieved from https://idiyas.com/inventor/thomas-elliot-rabe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 59 

% Patents Active = 89.8

 

 

Average Co-Inventor Count = 4.1

ph-index = 19

Forward Citations = 1,073(Granted Patents)

Forward Citations (Not Self Cited) = 853(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Baltimore, OH (US) (2017)
  • Baltimore, MD (US) (2000 - 2024)

Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cosmetic Ink Composition
Surface Tension Modifier
Keratinous Surfaces
Material Dispensing
Applicator Heads
Personal Care Devices
Inkjet Printing
Semi-Permanent Mascara
Surface Modification
Handheld Treatment Apparatus
Service Stations
59 patents (USPTO):Explore Patents

Title: Innovations of Thomas Elliot Rabe in Cosmetic Ink Technologies

Introduction

Thomas Elliot Rabe is a prominent inventor based in Baltimore, MD, with an impressive portfolio of 59 patents to his name. His work primarily focuses on creating innovative formulations in the cosmetic ink industry, paving the way for advanced applications in makeup and printing technologies.

Latest Patents

Rabe's latest innovations include a significant patent for a "Stable Cosmetic Ink Composition". This composition features a combination of particulate material, a (meth)acrylic acid homopolymer or its salt, and a rheology modifier. The particulate material in this formulation has a Particle Size Distribution D50 ranging from about 100 nm to about 2,000 nm. Additionally, the (meth)acrylic acid homopolymer presents a weight average molecular weight of less than about 20,000 daltons. The selected rheology modifiers include alkali swellable emulsion polymers and their hydrophobically modified variants, which contribute to the unique viscosity characteristics of the composition, making it suitable for various applications.

Another notable patent from Rabe is for a "Heterogeneous Cosmetic Ink Composition for Inkjet Printing Applications". This innovation also comprises a particulate material, a polymeric dispersant with a weight average molecular weight of less than about 20,000 daltons, and a polymeric rheology modifier. This composition undergoes controlled syneresis, forming a weak colloidal gel phase, allowing for efficient printing without the need for constant agitation or mixing, thus streamlining the printing process.

Career Highlights

Throughout his career, Rabe has contributed significantly to the field of cosmetic formulations while working with notable companies such as The Procter & Gamble Company. His expertise has led to groundbreaking advancements in the way cosmetics are formulated and applied, emphasizing both stability and usability in innovative inks.

Collaborations

Rabe has had the privilege of collaborating with distinguished individuals in the industry, including Faiz Feisal Sherman and Stephan Gary Bush. These partnerships have undoubtedly enhanced his work, allowing for diverse inputs and insights, which contribute to the refinement of his inventions.

Conclusion

Thomas Elliot Rabe continues to be a leading figure in the realm of cosmetic ink innovations. His inventive solutions are shaping the industry, enhancing the performance and application of cosmetics. As he pushes the boundaries of what is possible in cosmetic formulations, his dedication to innovation sets a precedent for future inventors in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…